Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Shifting Paradigms in Ovarian Cancer

EP. 1: Risk-Reducing Surgery in Epithelial Ovarian Cancer

April 29th 2019

EP. 2: Ovarian Cancer: Neoadjuvant Chemo Vs Primary Debulking

April 29th 2019

EP. 3: Secondary Debulking Surgery in Ovarian Cancer

April 29th 2019

EP. 4: Current Role of VEGF-Targeted Therapy in Ovarian Cancer

April 29th 2019

EP. 5: SOLO-1 and PARP Inhibitors in Ovarian Cancer

April 29th 2019

EP. 6: Detecting Somatic BRCA1/2 Mutations in Ovarian Cancer

April 29th 2019

EP. 7: PARP + Maintenance Bevacizumab in Ovarian Cancer

April 29th 2019

EP. 8: Approaching Platinum-Sensitive Recurrent Ovarian Cancer

April 29th 2019

EP. 9: Ovarian Cancer: Selecting Between Available PARPs

April 29th 2019

EP. 10: Ovarian Cancer: Predictors of PARP Sensitivity

April 29th 2019

EP. 11: PARP Inhibitors in Ovarian Cancer: Safety Profile

April 29th 2019

EP. 12: Ovarian Cancer: Recurrence After PARP Inhibition

April 29th 2019

EP. 13: Rationale for Immunotherapy in Ovarian Cancer

April 29th 2019

EP. 14: I/O Combination Strategies in Ovarian Cancer

April 29th 2019

EP. 15: Ongoing Research in Ovarian Cancer

April 29th 2019

EP. 16: Outlook in Treating Patients With Ovarian Cancer

April 29th 2019
Advertisement
Advertisement

Trending on OncLive

1

FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC

2

PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings

3

Dr Falchi on Critical Unmet Needs and Important Next Steps in DLBCL

4

Olverembatinib Plus Blinatumomab Yields High Early-Phase CR/CRi Rates in R/R Ph+ CML and B-ALL

5

META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us